Novavax Inc said on Friday its COVID-19 vaccine candidate showed immune response and protection against the SARS-CoV-2 Beta variant, which was originally identified in South Africa, in three animal and human studies.
https://whtc.com/2021/06/11/novavax-says-covid-19-vaccine-candidate-shows-immune-response-against-beta-variant/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.